Long non-coding RNA HEIH: a novel tumor activator in multiple cancers

J Sun, M Ni - Cancer Cell International, 2021 - Springer
The last decade has witnessed the altered expression levels of long non-coding RNA HEIH
in different types of cancer. More than half of the HEIH studies in cancer have been …

Quantitative estimates of the regulatory influence of long non-coding RNAs on global gene expression variation using TCGA breast cancer transcriptomic data

X Xie, S Sinha - PLOS Computational Biology, 2024 - journals.plos.org
Long non-coding RNAs (lncRNAs) have received attention in recent years for their
regulatory roles in diverse biological contexts including cancer, yet large gaps remain in our …

Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network

RS Ferraz, JVF Cavalcante, L Magalhães… - Cancer …, 2023 - Wiley Online Library
Background Metastatic castration‐resistant prostate cancer (mCRPC) is an aggressive form
of cancer unresponsive to androgen deprivation therapy (ADT) that spreads quickly to other …

GCEN: An easy-to-use toolkit for gene co-expression network analysis and lncRNAs annotation

W Chen, J Li, S Huang, X Li, X Zhang, X Hu… - Current Issues in …, 2022 - mdpi.com
Gene co-expression network analysis has been widely used in gene function annotation,
especially for long noncoding RNAs (lncRNAs). However, there is a lack of effective cross …

The Potential of NORAD–PUMILIO–RALGAPB Regulatory Axis as a Biomarker in Breast Cancer

CSM Muller, IS Giner, ÉP Zambalde, TM Carvalho… - Non-coding RNA, 2022 - mdpi.com
Introduction: Long non-coding RNAs (LncRNA) represent a heterogeneous family of RNAs
that have emerged as regulators of various biological processes through their association …